Premium
Three cases of endometrial cancer associated with “bioidentical” hormone replacement therapy
Author(s) -
Eden John A,
Hacker Neville F,
Fortune Michael
Publication year - 2007
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2007.tb01210.x
Subject(s) - medicine , officer , endometrial cancer , family medicine , cancer , history , archaeology
We describe three women who developed endometrial cancer after taking "bioidentical" hormone replacement therapy (HRT) to relieve menopausal symptoms. Although pharmaceutical HRT is a well established and tested therapy, little is known about the quality control, safety and efficacy of bioidentical HRT. Women should be advised to avoid bioidentical HRT, and those who continue to use it should receive regular endometrial surveillance.